| |
 |
 |
 |
 |
 |
 |
 |
 |
|
| HOME
> About Us > The Management team |
|
|
|
 |
|
|
 |
 |
 |
|
| Chairman of the Board, Chairman |
|
Shirow Enoki |
|
 |
Representative Director,
President and Chief Executive Officer |
|
Ei Yamada |
|
|
| Member of the Board |
|
Shunsuke Sami |
|
|
| Member of the Board |
|
Koji Nakamoto |
|
|
| Member of the Board |
|
Ryuichi Morishita |
|
|
| Member of the Board |
|
Ichiro Kitasato |
|
|
| Standing Corporate Auditor |
|
Noriaki Ohmura |
|
|
| Corporate Auditor |
|
Shinji Toyama |
|
|
| Corporate Auditor |
|
Tadashi Hishida |
|
|
|
 |
 |
Chairman of the Board, Chairman
Shirow Enoki
Date of Birth :
October 3 , 1937 |
| Career Summary |
| April 1960 |
Mitsubishi Kasei Corporation
(present Mitsubishi Chemical Corporation) |
| June 1991 |
Monsanto Kasei Co., Ltd.
(Director & Admin Manager) |
| March 1994 |
SEIKAGAKU CORPORATION
(Executive Board Member) |
| April 1994 |
Planning Manager,
SEIKAGAKU CORPORATION |
| June 1994 |
Director and Planning Manager,
SEIKAGAKU CORPORATION |
| June 1996 |
Executive Managing Director,
SEIKAGAKU CORPORATION |
| June 1998 |
President,
SEIKAGAKU CORPORATION |
| March 2003 |
Director,
AnGes MG, Inc. |
| June 2005 |
Chairman,
SEIKAGAKU CORPORATION |
| October 2007 |
Chairman,
AnGes MG, Inc. (current) |
|
 |
Representative Director, President and Chief Executive Officer
Ei Yamada/PhD
Date of Birth :
June 27, 1950 |
| Career Summary |
| April 1982 |
Mitsubishi Kasei Corporation (present Mitsubishi Chemical Corporation) |
| January
1995 |
Sosei K.K. |
| August
2000 |
Takara Shuzo Co., Ltd.
Director, Dragon Genomics Inc. (present Takara Bio Inc.) |
| May 2001 |
General Manager of Business
Development,
AnGes MG, Inc. |
| August
2001 |
Director, AnGes MG, Inc. |
| June 2002 |
CEO, AnGes Euro Limited (- present) |
| September
2002 |
President and CEO, AnGes MG, Inc. (- present) |
|
|
Member of the Board, Executive Vice President and Corporate Officer
Shunsuke Sami/PhD
Date of Birth :
February 22, 1954 |
| Career Summary |
| April 1978 |
Sumitomo Chemical Co., Ltd. |
| April 1984 |
Sumitomo Pharmaceuticals Co., Ltd. (present Dainippon Sumitomo Pharma Co., Ltd.) |
| June 1991 |
Assistant Manager, Research Planning Department, Sumitomo Pharmaceuticals Co., Ltd. (present Dainippon Sumitomo Pharma Co., Ltd.) |
| July 1995 |
Assistant Manager, R&D Coordination Department, Sumitomo Pharmaceuticals Co., Ltd. (present Dainippon Sumitomo Pharma Co., Ltd.) |
| April 2001 |
Manager, Business Development & Licensing Office,
Sumitomo Pharmaceuticals Co., Ltd. (present Dainippon Sumitomo Pharma Co., Ltd.) |
| March 2003 |
CEO, Sumitomo Pharmaceuticals America, Inc. (present Dainippon Sumitomo Pharma America, Inc.) |
| May 2007 |
Corporate Officer, Director of Business Development, IMMD Inc. |
| January 2008 |
Bristol-Myers K.K. |
| April 2008 |
Director, Business Development, Bristol-Myers K.K. |
| September 2008 |
Corporate Officer, AnGes MG, Inc. (- present ) |
| March 2009 |
Member of the Board, Executive Vice President, AnGes MG, Inc. (- present) |
| July 2010 |
CEO, AnGes, Inc. (- present) |
|
|
Member of the Board, Corporate Officer and Chief Intellectual Property Officer
Koji Nakamoto
Date of Birth :
September 26, 1953 |
| Career Summary |
| April 1978 |
Eisai Co., Ltd. |
| April 1999 |
Senior Manager, Intellectual Property Div., Eisai Co., Ltd. |
| June 2002 |
AnGes MG, Inc. |
| October 2003 |
Director, Business Development, Intellectual Property Div., AnGes MG, Inc. |
| April 2006 |
Senior Director and Chief Intellectual Property Officer, Business Development Dept., Intellectual Property Div., AnGes MG, Inc. |
| September 2007 |
Corporate Officer and Chief Intellectual Property Officer, AnGes MG, Inc. (- present) |
| March 2008 |
Member of the Board, AnGes MG, Inc. (- present) |
|
|
Member of the Board
Ryuichi Morishita
/ MD, PhD
Date of Birth :
May 12, 1962 |
| Career Summary |
| April 1991 |
Postdoctoral Fellow,
Osaka University Medical School |
| August
1991 |
Postdoctoral Fellow,
Stanford University School of Medicine |
| July 1992 |
Special Researcher,
American Society of Cardiovascular Medicine |
| May 1994 |
Special Researcher at
the Atheneum |
| October
1996 |
Assistant Professor,
Department of Geriatric Medicine
Osaka University Graduate school of Medicine |
| October
1998 |
Associate Professor,
Department of Geriatric Medicine
Osaka University Graduate school of Medicine Associate
Professor,
Division of Gene Therapy Science
Osaka University Graduate school of Medicine |
| January
2000 |
Visiting Professor,
The University of Hong Kong |
| November
2000 |
Director, AnGes MG, Inc.(current) |
| March 2003 |
Professor, Department of
Clinical Gene Therapy, Osaka University Graduate School
of Medicine(current) |
|
|
Member of the Board
Ichiro Kitasato
/ PhD
Date of Birth :
June 18, 1932 |
| Career Summary |
| April 1955 |
Meiji Seika Kaisha, Ltd. |
| April 1985 |
Member of the Board, Meiji Seika Kaisha, Ltd. |
| June 1989 |
Senior Vice President, Member of the Board, Meiji Seika Kaisha, Ltd. |
| June 1991 |
Executive Vice President, President of Pharmaceuticals
Member of the Board, Meiji Seika Kaisha, Ltd. |
| June 1993 |
Senior Executive Vice President, President of Pharmaceuticals
Member of the Board, Meiji Seika Kaisha, Ltd. |
| June 1995 |
President, Member of the Board, Meiji Seika Kaisha, Ltd. |
| June 2003 |
Chairman of the Board, Meiji Seika Kaisha, Ltd. |
| June 2006 |
Chief Corporate Advisor, Meiji Seika Kaisha, Ltd. |
| March 2008 |
Member of the Board, AnGes MG, Inc. (current) |
| April 2008 |
Advisor, The Kitasato Institute (current) |
|
|
Corporate Auditor
Noriaki Ohmura
Date of Birth :
April 28, 1944 |
| Career Summary |
| April 1968 |
Sumitomo Chemical Co., Ltd. |
| April 1984 |
Sumitomo Pharmaceuticals Co., Ltd. (present Dainippon Sumitomo Pharma Co., Ltd.) |
| July 1991 |
General Manager, Corporate Planning Department
Sumitomo Pharmaceuticals Co., Ltd. (present Dainippon Sumitomo Pharma Co., Ltd.) |
| April 1994 |
General Manager, Clinical Development Division
Sumitomo Pharmaceuticals Co., Ltd. (present Dainippon Sumitomo Pharma Co., Ltd.) |
| July 1997 |
General Manager, Technology & Research Management Office, General Manager, Pharmaceutical Business Planning & Coordination Office, Sumitomo Chemical Co., Ltd. |
| April 2001 |
Managing Director, Sumitomo Seiyaku Biomedical Co., Ltd. (present DS Pharma Biomedical Co., Ltd.) |
| July 2007 |
Senior Corporate Officer, Kawanishi Holdings, Inc. |
| March 2009 |
Corporate Auditor, AnGes MG, Inc. (- present) |
|
|
Corporate Auditor
Shinji Toyama
Date of Birth :
December 21, 1942 |
| Career Summary |
| April 1965 |
Shionogi & Co., Ltd. |
| March 2000 |
Secretary-General, Kinki Bio-industry Development Organization |
| March
2002 |
Auditor, AnGes MG, Inc.
(current) |
| December 2002 |
Director, Bio-Sight Capital Co., Ltd.(current) |
| April 2003 |
Senior Director, NPO Kinki Bio-industry Development Organization (current) |
|
Corporate Auditor
Tadashi Hishida
Date of Birth :
August 14, 1942 |
| Career Summary |
| April 1970 |
Mitsubishi.Chemical Industries
Ltd. |
| September
1991 |
Dispatched to the Mitsubishi
Kasei Institute of Life Sciences and Director of Research
Coordination. |
| August
1995 |
General Manager of Advanced
Medicine Group, R&D Division, Pharmaceutical Company
of, Mitsubishi Chemical Corp. |
| April 2000 |
Managing Director, The
Dia Foundation for Research on Ageing Societies. |
| June 2002 |
Auditor,AnGes MG,Inc.(current) |
| August
2002 |
Management Professor for
the
Medical/Industrial Linking Office,
School of Medicine, Mie University (current) |
|
|
|
